 Delayed-Action Preparations
"Delayed-Action Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Dosage forms of a drug that act over a period of time by controlled-release processes or technology.
| Descriptor ID |
D003692
|
| MeSH Number(s) |
D26.255.210 E02.319.300.253
|
| Concept/Terms |
Controlled-Release Preparations- Controlled-Release Preparations
- Controlled Release Preparations
- Controlled-Release Preparation
- Controlled-Release Formulations
- Controlled Release Formulations
- Controlled-Release Formulation
Sustained-Release Preparations- Sustained-Release Preparations
- Sustained-Release Preparation
- Extended Release Preparations
- Extended Release Preparation
- Slow Release Formulation
- Sustained Release Formulations
- Sustained Release Formulation
- Extended Release Formulations
- Extended Release Formulation
|
Below are MeSH descriptors whose meaning is more general than "Delayed-Action Preparations".
Below are MeSH descriptors whose meaning is more specific than "Delayed-Action Preparations".
This graph shows the total number of publications written about "Delayed-Action Preparations" by people in this website by year, and whether "Delayed-Action Preparations" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1997 | 0 | 1 | 1 | | 1999 | 1 | 2 | 3 | | 2000 | 0 | 2 | 2 | | 2002 | 1 | 4 | 5 | | 2003 | 1 | 2 | 3 | | 2005 | 1 | 5 | 6 | | 2006 | 2 | 2 | 4 | | 2007 | 0 | 7 | 7 | | 2008 | 0 | 4 | 4 | | 2010 | 0 | 3 | 3 | | 2011 | 2 | 6 | 8 | | 2012 | 2 | 5 | 7 | | 2013 | 2 | 9 | 11 | | 2014 | 0 | 7 | 7 | | 2015 | 2 | 6 | 8 | | 2016 | 3 | 6 | 9 | | 2017 | 0 | 7 | 7 | | 2018 | 4 | 6 | 10 | | 2019 | 0 | 3 | 3 | | 2020 | 1 | 7 | 8 | | 2021 | 0 | 2 | 2 | | 2022 | 0 | 1 | 1 | | 2023 | 0 | 3 | 3 | | 2024 | 4 | 5 | 9 | | 2025 | 0 | 5 | 5 | | 2026 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Delayed-Action Preparations" by people in Profiles.
-
Hsu HE, Lodi S, Yan S, Bovell-Ammon BJ, Christine PJ, Tilhou AS, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment. JAMA Netw Open. 2026 Jul 01; 9(7):e2623280.
-
Escobedo HD, Schurr MJ, Nair DP. Nanogels for the targeted delivery of antibiotic and antimicrobial drugs. Ther Deliv. 2026 Feb; 17(2):125-138.
-
Alabi A, Kerr JS, Shah M, Khan A, Ma JD, Suhandynata RT, Momper JD, Tsunoda SM. Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended-Release Tacrolimus (LCPT) Using Grapefruit Juice. Clin Pharmacol Drug Dev. 2026 Jan; 15(1):e70016.
-
Bommanahalli Nagaraju K, Dey A, Kompella U, Chauhan A. Pharmacokinetic model for drug delivery by Ozurdex. Drug Deliv Transl Res. 2026 04; 16(4):1249-1261.
-
Alabi A, Ge M, Momper JD, Tsunoda SM, Kelner MJ, Fitzgerald RL, Suhandynata RT. Measurement of Whole Blood Tacrolimus Concentrations by LC-MS/MS and Immunoassay Methods: Influence of Immediate-Release vs Extended-Release Tacrolimus Formulations. J Appl Lab Med. 2025 May 02; 10(3):546-558.
-
Jewell JS, Rockhill KM, Burkett H, Black JC, Ellis MS, Dart R. Trends in XTAMPZA ER and other oxycodone misuse and abuse during COVID-19: A mosaic approach. J Opioid Manag. 2025 May-Jun; 21(3):249-259.
-
Lodi S, Yan S, Bovell-Ammon B, Christine PJ, Hsu HE, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data. Addiction. 2025 Aug; 120(8):1634-1645.
-
Li J, Patel SK, Sweeney Y, Patton D, Anderson P, Hillier SL, Rohan LC. Engineering vaginal film platform for mucoadhesion and sustained drug release for HIV-1 prevention. J Control Release. 2025 03 10; 379:696-707.
-
Y Bernstein E, Magane KM, Dukes KA, Palfai TP, Lee JH, Saitz R, Samet JH. Correlates of post-hospitalization naltrexone adherence for alcohol use disorder. Drug Alcohol Depend. 2024 Dec 01; 265:112470.
-
Coleman HJ, Yang Q, Robert A, Padgette H, Funke HH, Catalano CE, Randolph TW. Formulation of three tailed bacteriophages by spray-drying and atomic layer deposition for thermal stability and controlled release. J Pharm Sci. 2024 11; 113(11):3238-3245.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|